Mei-Ching Liu - Concepedia

Author

Mei-Ching Liu

Koo Foundation Sun Yat-Sen Cancer Center

Also Known As

Liu Mei-Ching, M C Liu, Mei-Ching Liu

Publications

2.4K

Citations

H-Index

Concepts

All Affiliations

Koo Foundation Sun Yat-Sen Cancer Center National Taiwan University Hospital Taipei Veterans General Hospital China Medical University Duke Medical Center

About

Mei-Ching Liu is an author at Koo Foundation Sun Yat-Sen Cancer Center specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	2K
2	Health Sciences	4	4	1.8K
3	Biostatistics	1	1	23
4	Immunology	1	1	17
5	Obstetrics	1	1	30

Mei-Ching Liu

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial Javier Cortés, David W. Cescon, Hope S. Rugo, The Lancet Chemotherapy Versus PlaceboBreast OncologyOncologyClinical TrialsBreast Cancer	2020	1.7K
Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer Carlos H. Barrios, Mei-Ching Liu, Soo Chin Lee, Breast Cancer Research and Treatment	2010	196
Unique features of breast cancer in Taiwan Skye Hongiun Cheng, Mei-Hua Tsou, Mei-Ching Liu, Breast Cancer Research and Treatment Breast OncologyMedicinePathologyBreast ImagingBreast Cancer	2000	103
Adherence to Quality Indicators and Survival in Patients With Breast Cancer Skye Hung‐Chun Cheng, C Jason Wang, Lin Jinlong, Medical Care	2009	74
Clinicopathological analysis of 598 malignant lymphomas in Taiwan: Seven-year experience in a single institution Ming-Yuan Lee, Tran‐Der Tan, An‐Chen Feng, American Journal of Hematology PathologySeven-year ExperienceMalignant LymphomasHematological MalignancyOncology	2006	48
Intrapleural Urokinase for the Treatment of Loculated Malignant Pleural Effusions and Trapped Lungs in Medically Inoperable Cancer Patients Li‐Han Hsu, Thomas C. Soong, An‐Chen Feng, Journal of Thoracic Oncology Surgical OncologyUrologyMedicinePleural EffusionPleural Disease	2006	44
Abstract PD2-04: Updated overall survival (OS) results from the phase III MONALEESA-7 trial of pre- or perimenopausal patients with hormone receptor positive/human epidermal growth factor receptor 2 negative (HR+/HER2−) advanced breast cancer (ABC) treated with endocrine therapy (ET) ± ribociclib Debu Tripathy, Seock‐Ah Im, Marco Colleoni, Cancer Research Breast OncologyAbstract Pd2-04Cardiovascular PharmacologyGynecologyRib Arm	2021	30
Validating a Prognostic Scoring System for Postmastectomy Locoregional Recurrence in Breast Cancer Skye Hung‐Chun Cheng, Stella Y. Tsai, Ben-Long Yu, International Journal of Radiation OncologyBiologyPhysics Prognostic Scoring SystemPrognostic EvaluationSurgical OncologyBreast OncologyMedicine	2012	23
Is it appropriate to apply the enhanced recovery program to patients undergoing laparoscopic rectal surgery? Chien‐Chih Chen, I‐Ping Huang, Mei-Ching Liu, Surgical Endoscopy Enhanced RecoveryEnhanced Recovery ProgramMedicinePatient SafetyPost-operative Care	2010	21
Long-term survival and stage I breast cancer subtypes Skye Hung‐Chun Cheng, Ben-Long Yu, Cheng‐Fang Horng, Journal of Cancer Research and Practice Her2 StatusSurgical OncologyBreast OncologyBreast Cancer PatientsMedicine	2015	19

Page 1